Format
Sort by
Items per page

Send to

Choose Destination

Best matches for NPAS3 schizophrenia:

Search results

Items: 1 to 20 of 26

1.

Protein misassembly and aggregation as potential convergence points for non-genetic causes of chronic mental illness.

Bradshaw NJ, Korth C.

Mol Psychiatry. 2018 Aug 8. doi: 10.1038/s41380-018-0133-2. [Epub ahead of print] Review.

PMID:
30089789
2.

Neuronal PAS Domain Proteins 1 and 3 Are Master Regulators of Neuropsychiatric Risk Genes.

Michaelson JJ, Shin MK, Koh JY, Brueggeman L, Zhang A, Katzman A, McDaniel L, Fang M, Pufall M, Pieper AA.

Biol Psychiatry. 2017 Aug 1;82(3):213-223. doi: 10.1016/j.biopsych.2017.03.021. Epub 2017 Apr 6.

PMID:
28499489
3.

The Curse of the Dolphins: Cognitive Decline and Psychosis.

Phelps R, Tsai A, Hagen A, Pinter J, Smith R, Stein MT.

J Dev Behav Pediatr. 2017 Feb/Mar;38 Suppl 1:S16-S18. doi: 10.1097/DBP.0000000000000302.

PMID:
28141710
4.

A Mutation in NPAS3 That Segregates with Schizophrenia in a Small Family Leads to Protein Aggregation.

Nucifora LG, Wu YC, Lee BJ, Sha L, Margolis RL, Ross CA, Sawa A, Nucifora FC Jr.

Mol Neuropsychiatry. 2016 Oct;2(3):133-144. Epub 2016 Jul 27.

5.

NPAS1-ARNT and NPAS3-ARNT crystal structures implicate the bHLH-PAS family as multi-ligand binding transcription factors.

Wu D, Su X, Potluri N, Kim Y, Rastinejad F.

Elife. 2016 Oct 26;5. pii: e18790. doi: 10.7554/eLife.18790.

6.

The Curse of the Dolphins: Cognitive Decline and Psychosis.

Phelps R, Tsai A, Hagen A, Pinter J, Smith R, Stein MT.

J Dev Behav Pediatr. 2016 May;37(4):343-5. doi: 10.1097/DBP.0000000000000302.

PMID:
27096574
7.

Cumulative role of rare and common putative functional genetic variants at NPAS3 in schizophrenia susceptibility.

González-Peñas J, Arrojo M, Paz E, Brenlla J, Páramo M, Costas J.

Am J Med Genet B Neuropsychiatr Genet. 2015 Oct;168(7):528-35. doi: 10.1002/ajmg.b.32324. Epub 2015 May 15.

PMID:
25982957
8.

Genetic markers of white matter integrity in schizophrenia revealed by parallel ICA.

Gupta CN, Chen J, Liu J, Damaraju E, Wright C, Perrone-Bizzozero NI, Pearlson G, Luo L, Michael AM, Turner JA, Calhoun VD.

Front Hum Neurosci. 2015 Mar 3;9:100. doi: 10.3389/fnhum.2015.00100. eCollection 2015.

9.

NPAS3 variants in schizophrenia: a neuroimaging study.

Bernier D, Macintyre G, Bartha R, Hanstock CC, McAllindon D, Cox D, Purdon S, Aitchison KJ, Rusak B, Tibbo PG.

BMC Med Genet. 2014 Mar 27;15:37. doi: 10.1186/1471-2350-15-37.

10.

A fast-evolving human NPAS3 enhancer gained reporter expression in the developing forebrain of transgenic mice.

Kamm GB, López-Leal R, Lorenzo JR, Franchini LF.

Philos Trans R Soc Lond B Biol Sci. 2013 Nov 11;368(1632):20130019. doi: 10.1098/rstb.2013.0019. Print 2013 Dec 19.

11.

A mutation in NPAS3 segregates with mental illness in a small family.

Yu L, Arbez N, Nucifora LG, Sell GL, Delisi LE, Ross CA, Margolis RL, Nucifora FC Jr.

Mol Psychiatry. 2014 Jan;19(1):7-8. doi: 10.1038/mp.2012.192. Epub 2013 Jan 22. No abstract available.

PMID:
23337948
12.

Expression of NPAS3 in the human cortex and evidence of its posttranscriptional regulation by miR-17 during development, with implications for schizophrenia.

Wong J, Duncan CE, Beveridge NJ, Webster MJ, Cairns MJ, Weickert CS.

Schizophr Bull. 2013 Mar;39(2):396-406. doi: 10.1093/schbul/sbr177. Epub 2012 Jan 6.

13.

Transcriptional regulation of neurodevelopmental and metabolic pathways by NPAS3.

Sha L, MacIntyre L, Machell JA, Kelly MP, Porteous DJ, Brandon NJ, Muir WJ, Blackwood DH, Watson DG, Clapcote SJ, Pickard BS.

Mol Psychiatry. 2012 Mar;17(3):267-79. doi: 10.1038/mp.2011.73. Epub 2011 Jun 28.

PMID:
21709683
14.

Cross-disorder genomewide analysis of schizophrenia, bipolar disorder, and depression.

Huang J, Perlis RH, Lee PH, Rush AJ, Fava M, Sachs GS, Lieberman J, Hamilton SP, Sullivan P, Sklar P, Purcell S, Smoller JW.

Am J Psychiatry. 2010 Oct;167(10):1254-63. doi: 10.1176/appi.ajp.2010.09091335. Epub 2010 Aug 16.

15.

Association of NPAS3 exonic variation with schizophrenia.

Macintyre G, Alford T, Xiong L, Rouleau GA, Tibbo PG, Cox DW.

Schizophr Res. 2010 Jul;120(1-3):143-9. doi: 10.1016/j.schres.2010.04.002. Epub 2010 May 14.

PMID:
20466522
16.

Chromosome abnormalities, mental retardation and the search for genes in bipolar disorder and schizophrenia.

Blackwood DH, Thiagarajah T, Malloy P, Pickard BS, Muir WJ.

Neurotox Res. 2008 Oct;14(2-3):113-20. doi: 10.1007/BF03033803. Review.

PMID:
19073419
17.

Schizopsychotic symptom-profiles and biomarkers: beacons in diagnostic labyrinths.

Palomo T, Kostrzewa RM, Beninger RJ, Archer T.

Neurotox Res. 2008 Oct;14(2-3):79-96. doi: 10.1007/BF03033800. Review.

PMID:
19073416
18.

Association of the NPAS3 gene and five other loci with response to the antipsychotic iloperidone identified in a whole genome association study.

Lavedan C, Licamele L, Volpi S, Hamilton J, Heaton C, Mack K, Lannan R, Thompson A, Wolfgang CD, Polymeropoulos MH.

Mol Psychiatry. 2009 Aug;14(8):804-19. doi: 10.1038/mp.2008.56. Epub 2008 Jun 3.

PMID:
18521090
19.

The contribution of failing adult hippocampal neurogenesis to psychiatric disorders.

Kempermann G, Krebs J, Fabel K.

Curr Opin Psychiatry. 2008 May;21(3):290-5. doi: 10.1097/YCO.0b013e3282fad375. Review.

PMID:
18382230
20.

Interacting haplotypes at the NPAS3 locus alter risk of schizophrenia and bipolar disorder.

Pickard BS, Christoforou A, Thomson PA, Fawkes A, Evans KL, Morris SW, Porteous DJ, Blackwood DH, Muir WJ.

Mol Psychiatry. 2009 Sep;14(9):874-84. doi: 10.1038/mp.2008.24. Epub 2008 Mar 4.

PMID:
18317462

Supplemental Content

Loading ...
Support Center